Orthofix Medical Inc.
OFIX
$16.30
-$0.46-2.75%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.08% | 17.32% | 28.94% | 43.54% | 62.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.08% | 17.32% | 28.94% | 43.54% | 62.06% |
| Cost of Revenue | -1.09% | 6.05% | 25.65% | 56.04% | 105.05% |
| Gross Profit | 11.28% | 23.22% | 30.55% | 38.12% | 46.31% |
| SG&A Expenses | 0.40% | 9.41% | 19.44% | 37.46% | 71.77% |
| Depreciation & Amortization | 13.28% | 28.19% | 34.89% | 66.73% | 78.21% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.56% | 7.85% | 20.62% | 41.65% | 79.45% |
| Operating Income | 42.86% | 39.41% | 22.51% | -29.36% | -342.34% |
| Income Before Tax | 16.68% | 13.02% | -2.93% | -67.73% | -739.71% |
| Income Tax Expenses | -21.87% | 5.44% | -28.43% | 14.44% | 32.94% |
| Earnings from Continuing Operations | 16.78% | 12.66% | -1.99% | -65.92% | -666.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.78% | 12.66% | -1.99% | -65.92% | -666.60% |
| EBIT | 42.86% | 39.41% | 22.51% | -29.36% | -342.34% |
| EBITDA | 98.59% | 81.12% | 62.19% | 1.03% | -4,717.98% |
| EPS Basic | 20.46% | 19.53% | 12.50% | -37.83% | -321.96% |
| Normalized Basic EPS | 22.51% | 28.99% | 19.76% | -9.15% | -126.07% |
| EPS Diluted | 20.54% | 19.61% | 12.60% | -37.33% | -320.60% |
| Normalized Diluted EPS | 22.51% | 28.99% | 19.76% | -9.21% | -126.28% |
| Average Basic Shares Outstanding | 4.02% | 16.63% | 33.27% | 55.17% | 83.30% |
| Average Diluted Shares Outstanding | 4.02% | 16.63% | 33.27% | 55.04% | 83.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
